<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Prostate Anat+Path]]></title><description><![CDATA[<p dir="auto">MRCS B Prostate Gland<br />
Stem: A 68-year-old man presents to his GP with a 6-month history of increasing urinary frequency, nocturia, and a weak urinary stream with hesitancy. He denies any haematuria or weight loss. On examination, his abdomen is soft and non-tender, with no palpable bladder.</p>
<p dir="auto">What are the superior and inferior relations of the prostate gland?</p>
<blockquote class="spoiler border-warning"><button class="btn btn-sm btn-ghost border">Spoiler</button><p class="d-none mt-3 text-sm">Superior – neck of the bladder<br />
Inferior – external urethral sphincter</p></blockquote>
<p dir="auto">Describe the zonal anatomy of the prostate. Which zone is most commonly affected by carcinoma, and which by benign hyperplasia?</p>
<blockquote class="spoiler border-warning"><button class="btn btn-sm btn-ghost border">Spoiler</button><p class="d-none mt-3 text-sm">Peripheral zone – largest zone, most common site of prostate carcinoma, palpable on DRE<br />
Transition zone – surrounds the urethra, most common site of benign prostatic hyperplasia<br />
Central zone – surrounds the ejaculatory ducts</p></blockquote>
<p dir="auto">What is the arterial supply to the prostate?</p>
<blockquote class="spoiler border-warning"><button class="btn btn-sm btn-ghost border">Spoiler</button><p class="d-none mt-3 text-sm">Inferior vesical artery, from the anterior division of the internal iliac artery.</p></blockquote>
<p dir="auto">What is the venous drainage of the prostate and how is it implicated in prostatic malignancy?</p>
<blockquote class="spoiler border-warning"><button class="btn btn-sm btn-ghost border">Spoiler</button><p class="d-none mt-3 text-sm">Prostatic venous plexus<br />
Has a connection with the valveless vertebral veins, which may be a passage of spread of malignancy.</p></blockquote>
<p dir="auto">Prostate symptoms can be classified as storage or voiding symptoms, give two examples of each.<br />
Storage</p>
<blockquote class="spoiler border-warning"><button class="btn btn-sm btn-ghost border">Spoiler</button><p class="d-none mt-3 text-sm">Frequency<br />
Nocturia<br />
Urgency<br />
Incontinence</p></blockquote>
<p dir="auto">Voiding</p>
<blockquote class="spoiler border-warning"><button class="btn btn-sm btn-ghost border">Spoiler</button><p class="d-none mt-3 text-sm">Terminal dribbling<br />
Slow stream<br />
Slow to start voiding</p></blockquote>
<p dir="auto">What is an important part of the examination of a male patient with storage or voiding symptoms? How may we distinguish between benign or malignant pathology?</p>
<blockquote class="spoiler border-warning"><button class="btn btn-sm btn-ghost border">Spoiler</button><p class="d-none mt-3 text-sm">Digital rectal examination.<br />
May feel a smooth enlargement suggestive of benign disease, or a craggy, hard mass, which would suggest malignant disease.</p></blockquote>
<p dir="auto">What tumour marker is used to help diagnose and monitor prostate cancer, and what are its limitations?</p>
<blockquote class="spoiler border-warning"><button class="btn btn-sm btn-ghost border">Spoiler</button><p class="d-none mt-3 text-sm">Prostate-specific antigen (PSA)<br />
Not specific to malignancy – can also be raised in BPH, prostatitis, and after instrumentation (e.g. catheterisation, DRE)<br />
Lacks sensitivity and specificity, so used alongside DRE and biopsy rather than as a standalone diagnostic test</p></blockquote>
<p dir="auto">Give two options for the pharmacological management of benign prostatic hyperplasia.</p>
<blockquote class="spoiler border-warning"><button class="btn btn-sm btn-ghost border">Spoiler</button><p class="d-none mt-3 text-sm">5-alpha reductase inhibitors – e.g. Finasteride.<br />
Anticholinergic agents – e.g. Tolterodine<br />
Alpha blockers can also be used.</p></blockquote>
<p dir="auto">Give two risk factors for prostate cancer.</p>
<blockquote class="spoiler border-warning"><button class="btn btn-sm btn-ghost border">Spoiler</button><p class="d-none mt-3 text-sm">Ethnicity – more common in people of black ethnicity.<br />
Age – people aged over 50 are much more likely to have prostate malignancy.</p></blockquote>
]]></description><link>https://isurg.org/topic/444/prostate-anat-path</link><generator>RSS for Node</generator><lastBuildDate>Wed, 15 Jul 2026 21:20:08 GMT</lastBuildDate><atom:link href="https://isurg.org/topic/444.rss" rel="self" type="application/rss+xml"/><pubDate>Wed, 15 Jul 2026 16:50:50 GMT</pubDate><ttl>60</ttl></channel></rss>